A critical analysis of Covax alliance and corresponding global health governance and policy issues
A scoping review
Bibliographic Data
| ID | 21880168 |
|---|---|
| Authors | Anjali Pushkaran (0009-0004-9329-2985, Manipal Academy of Higher Education), Vijay Kumar Chattu (0000-0001-9840-8335, University of Toronto, corresponding author), Prakash Narayanan (0000-0001-9361-3989, Manipal Academy of Higher Education) |
| Year | 2023 |
| Volume | 8 |
| Issue | 10 |
| Pages | e012168 |
| Publication date | 2023-10-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMJ Global Health (JOURNAL) |
| Journal identifiers | ISSN: 2059-7908 • E-ISSN: 2059-7908 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/bmjgh-2023-012168 |
| PMID | 37793808 |
| OpenAlex | W4387330629 |
| Language | EN |
| Citations received | 10 |
| References cited | 41 |
INTRODUCTION: The COVAX alliance is a novel approach to international partnership in global health intended to achieve the worthy goal of 'COVID-19 vaccine equity'. This study aimed to identify the implementation challenges and framework gaps of COVAX and to explore the interconnected global health policy and governance gaps in ensuring equity, accessibility and affordability of vaccines. METHODS: A scoping review was conducted to identify the implementation challenges and framework gaps of COVAX and related global health policy and governance gaps. A search was carried out in PubMed, Scopus, Springer Link and Embase databases. Manually searched the grey literature, such as official reports and articles. EndNote V.20 was used to manage the evidence screening, and data extraction was carried out in Microsoft Excel. RESULTS: Searches of four electronic databases and official UN, GAVI and WHO websites identified 4686 pieces of evidence. The 937 duplicates were removed, and the remaining 3749 articles were screened for the title and abstract. Most articles were eliminated as they do not address global COVAX or COVID-19 vaccine equity. The remaining 53 pieces of evidence were reviewed for full text, and ultimately 40 articles found eligible were included in the scoping review. CONCLUSIONS: The implementation challenges of COVAX were attributed mainly to the phenomenon of vaccine nationalism by rich countries. The future global health policy and governance structure must be re-examined to address the inadequacies of such novel super public-and-private partnership models
Alliance · Business · Corporate governance · General partnership · Global governance · Global health · Grey literature · MEDLINE · Political science · Public health · Public relations · Scopus · Global Health and Surgery · Medicine · Nursing · Public Administration · Vaccine Coverage and Hesitancy · Viral Infections and Outbreaks Research · Health Policy
From margins to mastery
Shifting power dynamics in global health governance
Reconceptualizing vaccine nationalism
The normative chaos of the global arena. The Covid-19 pandemic as a litmus test for the health emergency management and global health systems
Covid-19 vaccination implementation in six lower- and middle-income countries
‘Our project, your problem?’ A case study of the WHO’s mRNA technology transfer programme in South Africa
“You can’t see what you’ve never had to live”—Cultivating imagination and solution spaces in global health and development
Strengthening the mpox response
Financing pandemic prevention, preparedness and response
Global health security
Challenges in ensuring global access to Covid-19 vaccines
Decolonising human rights
Covax and the many meanings of sharing
Incentivising wealthy nations to participate in the Covid-19 Vaccine Global Access Facility (Covax)
Are asylum seekers, refugees and foreign migrants considered in the Covid-19 vaccine discourse
Love thy neighbour? Allocating vaccines in a world of competing obligations
WHO’s allocation framework for Covax
Risky business
Covax, vaccine donations and the politics of global vaccine inequity
Redressing Covid-19 vaccine inequity amidst booster doses
Covax and the rise of the ‘super public private partnership’ for global health
The Inefficient and Unjust Global Distribution of Covid-19 Vaccines
The waiver of Covid-19 vaccine patents
Scoping studies
Covid-19 and Global Distributive Justice
| Citations per year | 5 |
|---|---|
| Citation span | 2024 - 2026 (3) |
| Highly cited | No |